Don’t miss anything. Follow Us.


Dr. Amol Ratnakar Suryawanshi


Degree University/Institution
M.V.Sc. (Genetics and Animal Breeding)Bombay Veterinary College, Mumbai Dr. Balasaheb Sawant Konkan Krishi Vidyapeeth, Dapoli (MS).
Ph.D. (Applied Biology)National Institute for Research in Reproductive Health (Indian Council of Medical Research), Mumbai (MS) University of Mumbai.

Work Experience

Position University/Organisation Period
Scientist-E and Adjunct Associate Professor, Regional Centre for Biotechnology (RCB), FaridabadInstitute of Life Sciences, Bhubaneswar-751023January 2007-March 2009
Scientist-D and Adjunct Associate Professor, Regional Centre for Biotechnology (RCB), FaridabadInstitute of Life Sciences, Bhubaneswar-751023April 2009-December 2013
Scientist-CInstitute of Life Sciences, Bhubaneswar-751023
Scientist-BInstitute of Life Sciences, Bhubaneswar-751023

Awards & Recognition

  1. Recipient of HUPO2009 Young Investigator Award at International Conference “HUPO 8th Annual World Congress with scientific theme: Proteomics of Human Health, Environment, and Disease” (HUPO2009 Congress), organized at The Westin Harbour Castle, Toronto, Canada from Sept 26-30, 2009
  2. Recipient of Senior Research Fellowship from Indian council of Medical Research



Clinical Proteomics

Broad research activities

Understanding of cancer and viral diseases through clinical proteomics

Our aim is to understand changes in cellular proteome due to various biological/disease conditions using advanced quantitative and targeted proteomics approaches.

At present, our lab is mainly focused on cancers (such as Nasopharyngeal Carcinoma, cervical/ovarian/endometrial cancer) and various viral diseases (such as Chikungunya, Dengue,  Rabies, COVID-19). We are interested to add many more diseases which are more relevant in this geographical region.

Ongoing /completed  Research projects/areas:

      Virus proteomics:

  1. Differential proteomics and genetics approach to reveal the cause of recent Chikungunya virus outbreak in India.
  2. Identification and Characterization of differentially expressed proteins in rabid animals: Implication in understanding pathogenesis
  3. Proteomics study to explore the signature molecules associated with severe pathogenesis of SARS-CoV-2 infection

      Cancer proteomics:

  1. Differential proteomics approach to identify and characterize protein/s involved in Nasopharyngeal Carcinoma (NPC)
  2. Epidemiology of Cervical, Endometrial and Ovarian cancers and their association with viral pathogens and tumour markers: A case-control study in Odisha

Research focus of lab :

  1. Disease Proteome Mapping
  2. Bio-marker discovery in various clinical diseases
  3. To decipher the role of important protein/s in disease pathogenesis
  4. Identification and characterization of post-transnational modifications (PTMs) with respect to their role in disease pathogenesis

Our group is working on identifications and Characterization of Bio-markers in various Diseases, identification of PTMs and their role in disease pathogenesis using high throughput mass spectrometry-based proteomics approaches. We used various advanced proteomics approaches such as gel-based, non-gel-based, labeled, labeled free proteomics approaches in our experiments.



Clinical Proteomics

Selected Publications

  1. Behera S, Reddy RR, Taunk K, Rapole S, Pharande RR, Suryawanshi AR. Delineation of altered brain proteins associated with furious rabies virus infection in dogs by quantitative proteomics. J Proteomics. 2022 Feb 20;253:104463. doi: 10.1016/j.jprot.2021.104463. Epub 2021 Dec 23. PMID: 34954397. (Impact factor 4.044)
  2. Prasad P, Mahapatra S, Mishra R, Murmu KC, Aggarwal S, Sethi M, Mohapatra P, Ghosh A, Yadav R, Dodia H, Ansari SA, De S, Singh D, Suryawanshi A, Dash R, Senapati S, Beuria TK, Chattopadhyay S, Syed GH, Swain R, Raghav SK, Parida A. Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of Mycobacterium and Mycoplasma in COVID-19 patients: a potential source of co-infection. Mol Omics. 2022 May 4. doi: 10.1039/d2mo00044j. Epub ahead of print. PMID: 35506682. (Impact factor 3.743)
  3. Ram AK, Mallik M, Reddy RR, Suryawanshi AR, Alone PV. 2022. Altered proteome in translation initiation fidelity defective eIF5G31R mutant causes oxidative stress and DNA damage. Scientific Reports 12:5033. (Impact factor 4.380)
  4. Panda S, Nanda A, Sahu N, Ojha DK, Pradhan B, Rai A, Suryawanshi A R, Banavali N, Nayak S. 2022. SufB intein splicing in Mycobacterium tuberculosis is influenced by two remote conserved N-extein histidines. Bioscience Reports 42. (3): BSR20212207. doi: (Impact factor 3.840)
  5. Chatterjee S, Datey A, Sengupta S, Ghosh A, Jha A, Walia S, Singh S, Suranjika S, Bhattacharya G, Laha E, Keshry SS, Ray A, Pani SS, Suryawanshi AR, Dash R, Senapati S, Beuria TK, Syed GH, Prasad P, Raghav SK, Devadas S, Swain RK, Chattopadhyay S, Parida A. 2021. Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India. Frontiers in Cellular and Infection Microbiology 11. (Impact factor 5.292) (Online: 21 Dec 2021)
  6. Behera S., Pharande R. R., Reddy R. R., Majee S. B., Mukherjee S., and Suryawanshi A. R.*. (2020). Quantitative proteomics leads to identify dog brain proteins involved in rabies virus infection: Implication in understanding viral pathophysiology.  Journal of proteins and proteomics 11, 241–257.
  7. Suresh V, Mohanty V, Avula K, Ghosh A, Singh B, Reddy RK, Parida D, Suryawanshi AR, Raghav SK, Chattopadhyay S, Prasad P, Swain RK, Dash R, Parida A, Syed GH, Senapati S. (2021). Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity. FASEB J. Jul;35(7):e21713. doi: 10.1096/fj.202100431R. PMID: 34105201.
  8. Das P, Badhe MR, Sahoo PK, Reddy RRK, Suryawanshi AR, Mohanty J. Immunoproteomic analysis of fish ectoparasite, Argulus siamensis antigens. Parasite Immunol. (2021) Apr 2:e12837. doi: 10.1111/pim.12837. Epub ahead of print. PMID: 33811350. (Impact factor: 2.05)
  9. Chatterjee K, De S, Deb Roy S, Sahu SK, Chakraborty A, Ghatak S, Das N, Mal S, Roy Chattopadhyay N, Das P, Reddy RR, Mukherjee S, Das AK, Puii Z, Zomawia E, Singh YI, Tsering S, Riba K, Rajasubramaniam S, Suryawanshi AR, Choudhuri T. (2021) BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach. Asian Pac J Cancer Prev. Apr 1;22(4):1171-1181. doi: 10.31557/APJCP.2021.22.4.1171. PMID: 33906310. (Impact factor: 1.58).
  10. Raghav S*, Ghosh A, Turuk J, Kumar S, Jha A, Madhulika S, Priyadarshini M, Biswas VK, Shyamli PS, Singh B, Singh N, Singh D, Datey A, Kiran A, Smita S, Sabat J, Bhattacharya D, Kshatri JS, Vasudevan D, Suryawanshi AR, Dash R, Senapati S, Beuria TK, Swain R, Chattopadhyay S, Syed GH, Dixit A, Prasad P, Pati S, Parida A*. (2020). Analysis of Indian SARS-CoV-2 genomes reveal prevalence of D614G mutation in Spike protein eliciting increase in interaction with TMPRSS2 and virus infectivity. Frontiers in Microbiology (accepted on 21st October 2020, In press) (Impact factor: 4.23)
  11. Roy Chattopadhyay N, Chatterjee K, Tiwari N, Chakrabarti S, Sahu SK, Deb Roy S, Ghosh A, Reddy RR, Das P, Mal S, Karnar BB, Das AK, Tsering S, Riba K, Puii Z, Zomawia E, Singh YI, Suryawanshi AR, Kumar A, Ganguly D, Goswami C, Choudhuri T. TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma. iScience. 2020 Mar 27;23(3):100937. doi: 10.1016/j.isci.2020.100937. PMID: 32179470 (Impact factor: 4.4)
  12. Mohanty J, Sahoo S, Badhe MR, Pillai BR, Sahoo PK, Suryawanshi AR, Patnaik BB. Lectin-Like Activity of Hemocyanin in Freshwater Prawn, Macrobrachium rosenbergii. Protein J. 2020 Aug;39(4):358-365. doi: 10.1007/s10930-020-09912-1. PMID: 32661731(Impact factor: 1.3)
  13. Kakar-Bhanot R, Brahmbhatt K, Kumar V, Suryawanshi AR, Srivastava S, Chaudhari U, Sachdeva G. Plasma membrane proteome of adhesion-competent endometrial epithelial cells and its modulation by Rab11a. Mol Reprod Dev. 2019 Nov 18. doi: 10.1002/mrd.23292. [Epub ahead of print] PubMed PMID: 31737970 (Impact factor: 3.113)
  14. Roy Chattopadhyay N, Chakrabarti S, Chatterjee K, Deb Roy S, Kumar Sahu S, Reddy RR, Das P, Bijay Kanrar B, Kumar Das A, Tsering S, Puii Z, Zomawia E, Singh YI, Suryawanshi A, Choudhuri T. Histocompatibility locus antigens regions contribute to the ethnicity bias of Epstein-Barr virus-associated nasopharyngeal carcinoma in higher-incidence populations. Scand J Immunol. 2019 Oct;90(4):e12796. doi: 10.1111/sji.12796. PubMed PMID: 31145476 (Impact factor: 2.563).
  15. Mukherjee S, Sengupta N, Chaudhuri A, Akbar I, Singh N, Chakraborty S, Suryawanshi AR, Bhattacharyya A, Basu A. PLVAP and GKN3 Are Two Critical Host Cell Receptors Which Facilitate Japanese Encephalitis Virus Entry Into Neurons. Sci Rep. 2018 Aug 6;8(1):11784. doi: 10.1038/s41598-018-30054-z.
  16. Sahu SK, Chakrabarti S, Roy SD, Baishya N, Reddy RR, Suklabaidya S, Kumar A, Mohanty S, Maji S, Suryanwanshi A, Rajasubramaniam S, Asthana M, Panda AK, Singh SP, Ganguly S, Shaw OP, Bichhwalia AK, Sahoo PK, Chattopadhyay NR, Chatterjee K, Kundu CN, Das AK, Kannan R, Zorenpuii, Zomawia E, Sema SA, Singh YI, Ghosh SK, Sharma K, Das BS, Choudhuri T. Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case-control study and meta-analysis. Oncogenesis. 2016 May 9;5:e225. doi: 10.1038/oncsis.2016.31. PubMed PMID: 27159678 (Impact factor: 3.952).
  17. Sengupta N, Mukherjee S, Tripathi P, Kumar R, Suryawanshi AR, Basu A. Cerebrospinal Fluid Biomarkers of Japanese Encephalitis [version 2; referees: 3 approved]. F1000Research 2015, 4:334 (doi: 10.12688/f1000research.6801.2).
  18. Swaroop S, Sengupta N, Suryawanshi AR, Adlakha YK, Basu A. HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis. J Neuroinflammation. 2016 Feb 2;13(1):27. doi: 10.1186/s12974-016-0486-x. (Impact factor: 5.408)
  19. Kumar S, Mamidi P, Kumar A, Basantray I, Bramha U, Dixit A, Maiti PK, Singh S, Suryawanshi AR, Chattopadhyay S, Chattopadhyay S. Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research. Arch Virol. 2015 Nov;160(11):2749-61. doi: 10.1007/s00705-015-2564-2. (Impact factor: 2.390)
  20. Pratheek BM, Suryawanshi AR, Chattopadhyay S, Chattopadhyay S. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection. Infect Genet Evol. 2015 Apr;31:118-26. doi: 10.1016/j.meegid.2015.01.017.
  21. Kumar A, Mamidi P, Das I, Nayak TK, Kumar S, Chhatai J, Chattopadhyay S, Suryawanshi AR, Chattopadhyay S. A novel 2006 Indian outbreak strain of chikungunya virus exhibits different pattern of infection as compared to prototype strain. PLoS One. 2014 Jan 20;9(1):e85714. doi: 10.1371/journal.pone.0085714. eCollection 2014 Jan 20.
  22. Chattopadhyay S, Kumar A, Mamidi P, Nayak TK, Das I, Chhatai J, Basantray I, Bramha U, Maiti PK, Singh S, Suryawanshi AR, Chattopadhyay S. Development and characterization of monoclonal antibody against non-structural protein-2 of Chikungunya virus and its application. J Virol Methods. 2014 Jan 21;199C: 86-94. doi: 10.1016/j.jviromet.2014.01.008.
  23. Joshi CS, Suryawanshi AR, Khan SA, Balasinor NH, Khole VV. Liprin α3: a putative estrogen regulated acrosomal protein. Histochem Cell Biol. 2013 Apr;139 (4):535-48.
  24. Suryawanshi AR, Khan SA, Joshi CS, Khole VV. Epididymosome Mediated Acquisition of MMSDH an Androgen Dependent and Developmentally Regulated Epididymal Sperm Protein. J Androl. 2012 Sep-Oct;33(5):963-74.
  25. Gajbhiye RK, Sonawani A, Khan SA, Suryawanshi AR, Kadam S, Warty N, Raut V, Khole VV. Identification and validation of novel serum markers for early diagnosis of endometriosis. Hum Reprod. 2012 Feb;27(2):408-17.
  26. Khan SA, Jadhav SV, Suryawanshi AR, Bhonde GS, Gajbhiye RK, Khole VV (2011). Evaluation of Contraceptive Potential of a Novel Epididymal Sperm Protein SFP2 in a Mouse Model. Am J Reprod Immunol. 2011 Sep;66(3):185-98.
  27. Suryawanshi AR, Khan SA, Gajbhiye RK, Gurav MY, Khole VV (2010). Differential Proteomics Leads to Identification of Domain Specific Epididymal Sperm Proteins. J Androl. 2011; 32(3):240-59.
  28. Khan S A*, Suryawanshi A R*, Ranpura S, Jadhav S, Khole V V. (2009). Identification of Novel Immunodominant Epididymal Sperm Proteins using Combinatorial Approach. Reproduction, 2009; 138: 81-93 (*Authors have equally contributed)
  29. Gajbhiye R K, Suryawanshi A R, Khan S A, Meherji P K, Warty N R, Raut V S, Chehna N A, Khole V V. (2008). Multiple endometrial antigens are targeted in autoimmune endometriosis. Reprod Biomed Online.; 16 (6):817-24.
  30. Suryawanshi A R., Kanadkhedkar H L., and Umrikar U D. (2004). Chromosome Analysis of Domestic Dogs. Indian Vet J.; 81:1071-1073.

Access full publication list: ‪Dr. Amol R Suryawanshi‬ – ‪Google Scholar‬



Clinical Proteomics
Dr. Amol Ratnakar Suryawanshi (PI)

My lab Members:  Group photo- 2022

Present Lab Members:

  • Ms. Nishi Pragnya Naik (JRF)
  • Ms. Arpita Kullu (JRF)
  • Ms. Rutuja Pradip Sawant (Project JRF)
  • Mr. Sridhar Behera (Project technician)
  • Mr. R. Rajendra Kumar Reddy
Ms. Nishi Pragnya Naik (JRF)
Ms. Arpita Kullu (JRF)
Ms. Rutuja Pradip Sawant (Project JRF)
Mr. Sridhar Behera (Project technician)
Mr. R. Rajendra Kumar Reddy, Lab Technician (Proteomics Facility Manager)

Doctoral Degree completed/ Ph.D. awarded:

  • Ms. Suchismita Behera– Awarded Ph.D.  degree for the thesis entitled, “Identification and characterization of differentially expressed proteins in rabies virus infection: Implication in understanding pathogenesis” in area Biotechnology from Regional Center for Biotechnology.

Lab alumni:

  • Dr. Bijayananda Panigrahi, Managing Director, Biopioneer Pvt.Ltd
  • Mr. Jagamohan Chhatai -Presently at CSIR-CCMB, Hyderabad

Lab Group photo-2019



Clinical Proteomics

Ongoing / completed Projects

Differential Proteomics and Genetics approach to reveal the cause of recent Chikungunya virus outbreak in India DBT, India 2011-2014
Studies on Chikungunya virus infection: Role of non-structural protein-2 and cellular proteins DBT, India 2010-2013
A Comprehensive understanding of the Nasopharyngeal Carcinoma (NPC) in the North-Eastern Region of India. (Multicentre project) DBT, India 2013-2016
Epidemiology of Cervical, Endometrial and Ovarian cancers and their association with viral pathogens and tumour markers: A case-control study in Odisha ICMR, India 2021-2024
Advance Mass Spectrometry Platform at Institute of Life Sciences, Bhubaneswar DBT, India 2021-2025
Proteomics study to explore the signature molecules associated with severe pathogenesis of SARS-CoV-2 infection ICMR, India 2022-2025


amol@ils.res.inNalco Square, C.S. Pur, Bhubaneswar-751023, India0091 674 23007280091 674 2304329 (D) / 2301476 ext. 329



Check our recent publication to get the highlight of our research work.



Post Doctoral fellows/Research Associate/N-PDF:

My laboratory is looking for prospective enthusiastic Post Doctoral fellows/Research associates, who are interested in the field of clinical proteomics, metabolomics and related areas. The candidates who have finished/finishing their Ph.D. with experience in proteomics, molecular/cell biology and handling omics data will be preferred. The candidates should have a valid postdoctoral fellowship from any funding agency (DBT/CSIR/ICMR/SERB etc.) or interested to apply for the fellowship in the in above mentioned research areas are encouraged to apply with their detailed CV, one page write-up describing their research interests and One/two page brief concept note of proposed research work to or .

I will be happy to guide prospective candidates through the research proposal and application process for obtaining Postdoc fellowships.

Ph.D. students:

Prospective Ph.D. students please refer to the Ph.D. Programme advertisement on ILS website for details.

We are looking for dedicated, meticulous, hard-working and calm student who is willing to accept the challenges to persue the research dream.

The candidates completed/completing their masters/post graduate degree and wish to pursue PhD in the field of clinical proteomics for understanding cancer and viral diseases may write to or along with your CV and research interest. Preference will be given to the student having valid CSIR/UGC/DBT/ICMR JRF or any other national fellowship.

Summer dissertation:

Students interested for summer dissertation, please refer to for details.

Students who wish to pursue summer trainees (minimum 2 months) and Master’s project (minimum 6 months) may write to or along with your CV and research interest.

Training and Workshop :

We frequently conduct training and workshop for various levels of programs in the area of proteomics. Interested may frequently visit ILS website to get information about such programs.